Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformat — 2017 Animal Study - Veterinary Clinical Trial | BudProfiles

Home

Studies

N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic T...

PositiveAnimal Study - Veterinary Clinical Trial2017

N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Cancer

Related Studies

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Limited 12-hour pharmacokinetic assessment of CBD and CBDA isolates compared to their full-spectrum extracts in healthy adult beagles

2025·Review/Other

N/A

The use of cannabidiol (CBD) to improve sleep: a systematic review

2025·Meta-analysis -

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

N/A

Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes

2025·Review/Other

Cannabinoids

N-Arachidonoyl Dopamine (NADA)

Organ Systems

Nervous System

Study Details

Type: Animal Study - Veterinary Clinical Trial
Year: 2017
Study ID: #2017119